Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
The Journal of Clinical Investigation|July 26, 2008
Immune response hinders therapy for lysosomal storage diseasesKatherine P PonderExpert Opinion on Biological Therapy|August 31, 2007
Gene therapy for mucopolysaccharidosisKatherine P Ponder, Mark E HaskinsMolecular Genetics and Metabolism|January 7, 2015
The effect of Tlr4 and/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII miceElizabeth M Xing, Susan Wu, Katherine P PonderHeart and Metabolism : Management of the Coronary Patient|March 4, 2016
Gene therapy for cardiovascular manifestations of lysosomal storage diseasesMeg M Sleeper, Mark E Haskins, Katherine P PonderHuman Gene Therapy|October 30, 2009
Neonatal intravenous injection of a gammaretroviral vector has a low incidence of tumor induction in miceMindy Tittiger, Xiucui Ma, Lingfei Xu, et al.Journal of Veterinary Cardiology : the Official Journal of the European Society of Veterinary Cardiology|June 7, 2011
Status of therapeutic gene transfer to treat cardiovascular disease in dogs and catsMeg Sleeper, Lawrence T Bish, Mark Haskins, et al.Molecular Genetics and Metabolism|September 19, 2006
Effect of neonatal administration of a retroviral vector expressing alpha-L-iduronidase upon lysosomal storage in brain and other organs in mucopolysaccharidosis I miceSarah Chung, Xiucui Ma, Yuli Liu, et al.Molecular Genetics and Metabolism|April 21, 2009
Mechanism of shortened bones in mucopolysaccharidosis VIIJason A Metcalf, Yanming Zhang, Matthew J Hilton, et al.Pageof 4